Abeona Therapeutics
ABEO
71 hedge funds and large institutions have $141M invested in Abeona Therapeutics in 2025 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 27 increasing their positions, 12 reducing their positions, and 8 closing their positions.
1,505% more call options, than puts
Call options by funds: $2.86M | Put options by funds: $178K
125% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 12
75% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 8
9% more funds holding
Funds holding: 65 → 71 (+6)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
9.3% less ownership
Funds ownership: 70.44% → 61.14% (-9.3%)
17% less capital invested
Capital invested by funds: $170M → $141M (-$29.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$3.38M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$1.53M |
| 3 |
JP Morgan Chase
New York
|
+$1.27M |
| 4 |
WSL
Western Standard LLC
Los Angeles,
California
|
+$1.07M |
| 5 |
Morgan Stanley
New York
|
+$1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$7.11M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$6.58M |
| 3 |
Walleye Capital
New York
|
-$2.19M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$734K |
| 5 |
6CM
683 Capital Management
New York
|
-$635K |
ABEO Hedge Fund Activity: Q1 2025 in Review
71 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics (ABEO) for Q1 2025, worth a combined $141M — down 17% from $170M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new ABEO positions and 8 closed out — a net gain of 6 holders — while 27 added to existing stakes and 12 trimmed.
The largest buyer was Kennedy Capital Management, opening a new position worth an estimated $3.38M. The largest seller was Millennium Management, cutting an estimated $7.11M.
- 71 institutional investors held Abeona Therapeutics (ABEO) as of Q1 2025, up from 65 in Q4 2024.
- Funds reported $141M of Abeona Therapeutics stock for Q1 2025, down 17% quarter-over-quarter.
- 14 funds opened new Abeona Therapeutics positions in Q1 2025 and 8 closed out, a net change of +6 holders.
- The largest Abeona Therapeutics buyer in Q1 2025 was Kennedy Capital Management, an estimated $3.38M added.
- The largest Abeona Therapeutics seller in Q1 2025 was Millennium Management, an estimated $7.11M sold.
Based on aggregated 13F filings for Q1 2025.